Basis Medical Technologies is a global distribution platform for novel technologies in medicine and medical aesthetics. Our experienced management and Medical Advisory Board are committed to delivering and developing quality medical products internationally.
BASIS is the exclusive medical channel market representative the Lumixyl™ peptide, a technology developed by dermatological researchers out of Stanford for the improvement of hyperpigmentation and licensed by Envy Medical Inc. Lumixyl™ has been shown to promote the reduction of melanin more efficaciously than hydroquinone and without irritation or other side effects of conventionally used skin brighteners. A physician-dispensed cosmetic, Lumixyl™ is formulated as a luxurious topical cream for use twice daily, by itself or in combination with in-office procedures for skin rejuvenation.
BASIS is also the exclusive market representative for DNA Performance Skincare™ with Patent Pending formulation, Nutraplex2C™. This revolutionary skincare system offers a unique combination of scientifically developed targeted ingredients and natural formulas that are free of synthetic oils and paraben preservatives. DNA Performance Skincare™ is a one-of-a-kind defense system against the elements that cause aging skin while simultaneously helping damaged skin regenerate. Whether you are using DNA Repair to reverse the appearance of aging, DNA Restore for dry damaged skin, or DNA Revive for tired eyes, DNA Performance Skincare™ will be highly effective.
BASIS holds non-exclusive rights for the SilkPeel™ Dermalinfusion™ system in the international market. This advanced aesthetic technology is the only system to offer simultaneous exfoliation, evacuation and the infusion of condition-specific solutions for the anti-aging, acne and hyperpigmentation. Scientifically validated, the versatility of this system is a fit for any aesthetic practice either as a stand-alone procedure or a means of optimizing results with laser, IPL and other light-based therapies.
BASIS is very excited about the other technologies we have pending in our pipeline. From dermatological products, devices and innovative products for general health, BASIS looks forward to continually participating in the innovation of the medical and medical aesthetics industries! Please contact us directly to stay informed about exciting developments.
BASIS believes that a solid foundation is critical to the success of any product in any market. In building a network of distributors that is responsive, efficient and far-reaching, we are able to secure our products in global markets with an immediacy and uniformity unique to our model. BASIS is also committed to research and product development. We support and facilitate the development of new technologies and the reinvigoration of existing ones through R&D, clinical trials and regulatory processes. Our products represent novel innovations from a variety of medical sectors. We are diversified, we are experienced
-we are where commercial development begins.